ACSF3 and metabolic dysfunction-associated steatotic liver disease: Compared to benzoic acid, protocatechinic acid with two additional hydrophilic groups provides more interaction sites with SIRT3 [152], enabling effective modulation of the SIRT3/ACSF3 pathway to ameliorate MASLD.